Artificial Intelligence4 years ago
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
Merck, a leading science and technology company, today announced the presentation of new efficacy data from the Phase IV MAGNIFY-MS study on MAVENCLAD® (cladribine tablets) in patients...
